Lirimilast
Chemical Structure Depiction of
Lirimilast
Lirimilast
Compound characteristics
| Compound ID: | CE01-9829 |
| Compound Name: | Lirimilast |
| Molecular Weight: | 443.26 |
| Molecular Formula: | C17 H12 Cl2 N2 O6 S |
| CAS Number: | 329306-27-6 |
| Smiles: | CS(=O)(=O)Oc1ccc2c(c(C(c3ccc(cc3[Cl])[Cl])=O)oc2c1)NC(N)=O |
| InChI Key: | YPFLFUJKZDAXRA-UHFFFAOYSA-N |
| Short Description: | Lirimilast is an effective, selective, and orally active phosphodiesterase-4 (PDE4) inhibitor (IC50: 49 nM). Lirimilast has potently anti-inflammatory properties. Lirimilast can be used for the treatm ent of asthma or chronic obstructive pulmonary disease. |
| Pathway: | Metabolism |
| Target: | PDE |
| Alias: | BAY 19-8004 |
| Stock amount: | 100 |